Metastatic colorectal cancer (mCRC) patient derived organoids (PDOs) as a preclinical tool to understand mechanisms of resistance to anti-angiogenic drugs. (March 2018) - Hedayat, Somaieh; Vlachogiannis, George; Jamin, Yann; Khan, Khurum; Fernandez-mateos, Javier; Hahne, Jens C.; Rata, Michaela; Koh, Dow-Ku; Tunariu, Nina; Collins, David; Bali, Monia; Chau, Ian; et al.